Trial · NCT05093790
Results by group280
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 280
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change From Baseline in Thrombus Area | Arm 1: 90 mg Ticagrelor + 4 mg BMS-986141 | On-treatment Day 1, Hour 2, Low Shear | 10.0 | Standard Deviation 260.3 | Percent Change |
| Percent Change From Baseline in Thrombus Area | Arm 2: 75 mg Aspirin + 4 mg BMS-986141 | On-treatment Day 1, Hour 2, Low Shear | 538.6 | Standard Deviation 1803.3 | Percent Change |
| Percent Change From Baseline in Thrombus Area | Arm 3: 90 mg Ticagrelor + 75 mg Aspirin + 4 mg BMS-986141 | On-treatment Day 1, Hour 2, Low Shear | 104.2 | Standard Deviation 383.5 | Percent Change |
| Percent Change From Baseline in Thrombus Area | Arm 4: Heathy Participants | On-treatment Day 1, Hour 2, Low Shear | -14.9 | Standard Deviation 50.2 | Percent Change |
| Percent Change From Baseline in Thrombus Area | Arm 1: 90 mg Ticagrelor + 4 mg BMS-986141 | On-treatment Day 1, Hour 2, High Shear | -23.0 | Standard Deviation 24.1 | Percent Change |
| Percent Change From Baseline in Thrombus Area | Arm 2: 75 mg Aspirin + 4 mg BMS-986141 | On-treatment Day 1, Hour 2, High Shear | -18.4 | Standard Deviation 27.5 | Percent Change |
| Percent Change From Baseline in Thrombus Area | Arm 3: 90 mg Ticagrelor + 75 mg Aspirin + 4 mg BMS-986141 | On-treatment Day 1, Hour 2, High Shear | -24.2 | Standard Deviation 17.2 | Percent Change |
| Percent Change From Baseline in Thrombus Area | Arm 4: Heathy Participants | On-treatment Day 1, Hour 2, High Shear | -27.7 | Standard Deviation 24.4 | Percent Change |
| Percent Change From Baseline in Thrombus Area | Arm 1: 90 mg Ticagrelor + 4 mg BMS-986141 | Post-treatment Day 2, Hour 24, Low Shear | 20.7 | Standard Deviation 134.6 | Percent Change |
| Percent Change From Baseline in Thrombus Area | Arm 2: 75 mg Aspirin + 4 mg BMS-986141 | Post-treatment Day 2, Hour 24, Low Shear | 579.6 | Standard Deviation 2125.4 | Percent Change |
| Percent Change From Baseline in Thrombus Area | Arm 3: 90 mg Ticagrelor + 75 mg Aspirin + 4 mg BMS-986141 | Post-treatment Day 2, Hour 24, Low Shear | 31.0 | Standard Deviation 130.0 | Percent Change |
| Percent Change From Baseline in Thrombus Area | Arm 4: Heathy Participants | Post-treatment Day 2, Hour 24, Low Shear | -2.5 | Standard Deviation 41.6 | Percent Change |
| Percent Change From Baseline in Thrombus Area | Arm 1: 90 mg Ticagrelor + 4 mg BMS-986141 | Post-treatment Day 2, Hour 24, High Shear | -4.8 | Standard Deviation 30.0 | Percent Change |
| Percent Change From Baseline in Thrombus Area | Arm 2: 75 mg Aspirin + 4 mg BMS-986141 | Post-treatment Day 2, Hour 24, High Shear | -3.5 | Standard Deviation 67.1 | Percent Change |
| Percent Change From Baseline in Thrombus Area | Arm 3: 90 mg Ticagrelor + 75 mg Aspirin + 4 mg BMS-986141 | Post-treatment Day 2, Hour 24, High Shear | -10.6 | Standard Deviation 24.0 | Percent Change |
| Percent Change From Baseline in Thrombus Area | Arm 4: Heathy Participants | Post-treatment Day 2, Hour 24, High Shear | -23.0 | Standard Deviation 22.2 | Percent Change |
| Number of Participants Experiencing Abnormal Vital Signs | Arm 1: 90 mg Ticagrelor + 4 mg BMS-986141 | DIASTOLIC BLOOD PRESSURE (MMHG) Day 1 > 90 AND CHANGE FROM BASELINE > 10 | 2 | Participants | |
| Number of Participants Experiencing Abnormal Vital Signs | Arm 2: 75 mg Aspirin + 4 mg BMS-986141 | DIASTOLIC BLOOD PRESSURE (MMHG) Day 1 > 90 AND CHANGE FROM BASELINE > 10 | 0 | Participants | |
| Number of Participants Experiencing Abnormal Vital Signs | Arm 3: 90 mg Ticagrelor + 75 mg Aspirin + 4 mg BMS-986141 | DIASTOLIC BLOOD PRESSURE (MMHG) Day 1 > 90 AND CHANGE FROM BASELINE > 10 | 0 | Participants | |
| Number of Participants Experiencing Abnormal Vital Signs | Arm 4: Heathy Participants | DIASTOLIC BLOOD PRESSURE (MMHG) Day 1 > 90 AND CHANGE FROM BASELINE > 10 | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05093790/results